ReviewCancers2022
Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines.
Riya Khetan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ReviewCancers2022
Riya Khetan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.